Head and Neck Diseases by Alexandros G.Sfakianakis: Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Recurrent or Metastatic Squamous Cell Cancers of the Head and Neck

Παρασκευή 2 Δεκεμβρίου 2016

Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Recurrent or Metastatic Squamous Cell Cancers of the Head and Neck

Condition: Squamous Cell Cancers of the Head and Neck
Interventions: Drug: cetuximab; Drug: afatinib
Sponsors: Aarti Bhatia; National Comprehensive Cancer Network; Boehringer Ingelheim
Not yet recruiting - verified November 2016

http://ift.tt/2ghi8SM

Head and Neck Diseases by Alexandros G.Sfakianakis

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Παρασκευή 2 Δεκεμβρίου 2016

Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Recurrent or Metastatic Squamous Cell Cancers of the Head and Neck

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου